HNSP was founded in 2000 and is a
publicly-traded company. We engage in development, manufacturing and marketing
of both APls and drug products. We have more than 10 management members with
oversea doctor degree and also oversea experience in R&D, manufacture
and/or registration. HNSP enjoys a strong team of regulatory registration,
and also a China-based sales force of over 400 agents. With excellent know-how
in peptide chemistry, HNSP is a leader in the field of peptide manufacture in
Most of our facilities were built based on the EU and US CGMP standards.
HNSP has been inspected respectively by USFDA and (Italy) AIFA and the GMP status was considered acceptable and spoken highly of.
Our Thymalfasin API and FDF has also been approved by (Italy) AIFA.We are open to discuss any forms of collaborations.
Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Primary business activity
Categories affiliated with Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation